| This article has been cited by |
| 1 | A Systematic Review of Pharmacovigilance Systems in Developing Countries Using the WHO Pharmacovigilance Indicators | |
| Hamza Y. Garashi,Douglas T. Steinke,Ellen I. Schafheutle |
| Therapeutic Innovation & Regulatory Science.2022;56(5)717 |
| [DOI] |
|
| 2 | What Future Healthcare Professionals Need to Know About Pharmacovigilance: Introduction of the WHO PV Core Curriculum for University Teaching with Focus on Clinical Aspects | |
| Rike van Eekeren,Leàn Rolfes,Andries S. Koster,Lara Magro,Gurumurthy Parthasarathi,Hussain Al Ramimmy,Tim Schutte,Daisuke Tanaka,Eugène van Puijenbroek,Linda Härmark |
| Drug Safety.2018;41(11)1003 |
| [DOI] |
|
| 3 | What Future Healthcare Professionals Need to Know About Pharmacovigilance: Introduction of the WHO PV Core Curriculum for University Teaching with Focus on Clinical Aspects | |
| Rabiu Yakubu,Abubakar Musa Isa,Ibrahim Jatau Abubakar,Ibrahim Oreagba,Ahmed Awaisu |
| Drug Safety.2020;41(11)525 |
| [DOI] |
|
| 4 | Stakeholders’ knowledge, attitudes and practices to pharmacovigilance and adverse drug reaction reporting in clinical trials: a mixed methods study | |
| David O. Riordan,Mary Kinane,Kieran A. Walsh,Frances Shiely,Joe Eustace,Margaret Bermingham |
| European Journal of Clinical Pharmacology.2020;76(10)1363 |
| [DOI] |
|
| 5 | Stimulated adverse drug reaction reporting in pharmacovigilance: Indian perspectives | |
| Anusha Thota,Siddharth Sarkar,Snehil Guptha,Prasad Thota |
| Journal of Pharmacovigilance and Drug Research.2021;2(2)13 |
| [DOI] |
|
| 6 | Strengths and Weaknesses of the Pharmacovigilance Systems in Three Arab Countries: A Mixed-Methods Study Using the WHO Pharmacovigilance Indicators | |
| Hamza Garashi,Douglas Steinke,Ellen Schafheutle |
| International Journal of Environmental Research and Public Health.2022;19(5)2518 |
| [DOI] |
|
| 7 | Teaching pharmacovigilance to undergraduate students: Our experience in poor-resource setting | |
| Mohammed Alshakka,Wafa Badullah,Abdullah AL-Dhuraibi,Sara Alshagga,MohamedIzham Mohamed Ibrahim |
| Journal of Pharmacy And Bioallied Sciences.2022;14(1)31 |
| [DOI] |
|
| 8 | Educating Healthcare Professionals in Pharmacovigilance: Global Trends and Korea’s Status | |
| So-Hee Park,Kyu Hyuck Chung,Byung-Joo Park,Dong Yoon Kang,Ju-Young Shin |
| Korean Medical Education Review.2020;22(1)32 |
| [DOI] |
|
| 9 | Farmacovigilância: uma estratégia biopolítica | |
| Cléber Domingos Cunha da Silva |
| Saúde e Sociedade.2018;27(3)860 |
| [DOI] |
|
| 10 | A systematic review on learning outcomes of pharmacovigilance issues: Undergraduates of pharmacy | |
| Carla Pires |
| International Journal of Educational Research.2021;109(3)101845 |
| [DOI] |
|
| 11 | Medical students as adverse drug event managers, learning about side effects while improving their reporting in clinical practice | |
| M. Reumerman,J. Tichelaar,M.C. Richir,M.A. van Agtmael |
| Naunyn-Schmiedeberg's Archives of Pharmacology.2021;394(7)1467 |
| [DOI] |
|
